Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Scientists are uncovering an unexpected potential for semaglutide, the active ingredient in popular weight-loss medications like Ozempic and Wegovy
These medications are prepared by FDA-registered, inspected compounding pharmacies
They identify contraindications, monitor adverse effects, and alter medication as the body responds
This class of compounds binds to key receptors in the brain, pancreas, and gastrointestinal (GI) tract, instigating several biological reactions: Enhances insulin secretion Slows gastric emptying Increases -cell proliferation Reduces glucagon release Mitigates hunger signaling These actions combine to regulate appetite, food intake, and the physical feeling of fullness (satiety)
Ongoing progress in peptide technologies plus drug delivery systems is speeding up how quickly new products move from idea to market
Chinas GLP-1 market is similarly expected to grow substantially, with analysts estimating it could reach RMB 100 billion (US$14 billion) by 2030
